SRTA
Strata Critica-A (SRTA)
NASDAQ
$5.54-$0.21 (-3.74%)
Price as of Jun 23, 2026 2:30 PM EDT
  • $497.5M
    Market Cap
  • N/A
    1-Year Change
  • Medical Care Facilities
    Industry

Key Performance

More
  • Earnings Score: 53
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: 97
TradeSmith Loading

Latest Research & News

Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call

Strata Critical Medical (Nasdaq: SRTA) announced it will release fourth quarter 2025 financial results on March 3, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Will Heyburn and Melissa Tomkiel. The company is a time-critical logistics and medical services provider specializing in organ transplant networks and surgical services.

02/10/2026, 4:00 PM • GlobeNewswire

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

Strata Critical Medical has appointed Will Cook, President and CEO of Vail Health, to its Board of Directors. Cook brings extensive healthcare leadership experience from roles at University of Colorado Hospital, UPMC, and Johns Hopkins Health System.

12/03/2025, 5:00 PM • GlobeNewswire

Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance

Strata Critical Medical outlined its growth strategy at its 2025 Investor Day, targeting high-teens organic Adjusted EBITDA growth and planning $200 million in potential acquisitions through 2029 in the transplant industry logistics market.

11/17/2025, 2:00 PM • GlobeNewswire

Strata Announces 2025 Investor Day

Strata Critical Medical, a time-critical logistics and medical services provider, announced its acquisition of Keystone Perfusion to expand its organ recovery platform. The acquisition is expected to generate approximately $65 million in revenue and $13 million in Adjusted EBITDA for the full year 2025.

09/30/2025, 4:00 PM • GlobeNewswire

Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services

Strata Critical Medical has acquired Keystone Perfusion Services for $124 million, expanding its medical services platform and creating a comprehensive organ transplant service provider with capabilities in surgical recovery, logistics, and perfusion services.

09/16/2025, 8:30 AM • Benzinga

Peers

Statistics

More
Day Range
$5.72
$5.88
$5.75
1-Year Range
$3.99
$6.47
$5.75
Latest Close$5.75
Change
-$0.13 (-2.26%)
Volume1,209,390
Market Cap$497.5M
Shares Outstanding86.5M
P/E (TTM)10.36
Diluted EPS (TTM)$0.56
Enterprise Value$438.8M

Information as of 06/22/2026

Company Profile

STRATA CRITICAL MEDICAL INC
STRATA CRITICAL MEDICAL INC
https://www.stratacritical.com
$497.5M
Market Cap
$47.0M
Net Income
Sector: Healthcare
Industry: Medical Care Facilities
666 Third Avenue, New York, NY, United States, 10017
(917) 781-3190

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Key Executives

  • Melissa Tomkiel
  • William A. Heyburn
  • Scott Wunsch
  • Amir Cohen
  • Scott Silvestry

Current Ownership Distribution

  • Other51.8M (59.82%)
  • Mutual Funds22.9M (26.49%)
  • Insiders11.9M (13.70%)
  • Institutions0 (0.00%)